StonvexLoading…
StonvexStonvexStonvexCore line items from IONS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $246.09M | $943.71M | $740.38M | $583.66M |
Operating Income | $-117.42M | $-381.68M | $-167.22M | $-7.04M |
Net Income | $-92.53M | $-381.39M | $-151.99M | $-23.39M |
EPS (Diluted) | $-0.56 | $-2.38 | $-0.95 | $-0.15 |
Total Assets | $3.45B | $3.52B | $3.03B | $2.99B |
Total Liabilities | $2.96B | $3.03B | $2.42B | $2.35B |
Cash & Equivalents | $173.38M | $372.26M | $338.34M | $297.30M |
Free Cash Flow OCF − CapEx | $-814.58M | $-320.03M | $-161.03M | $-24.32M |
Shares Outstanding | 165.90M | 163.30M | 161.14M | 159.20M |